V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240013852 | 240007633 | 0 | 75 | Disease modification (D) | 2016-03-09 | 2016-03-09 | Trial Unspecified | N | N | 240030198 | TRIAL |
| 240013853 | 240007637 | 1.85 | 72.5 | Palliative (P) | 2015-05-21 | 2015-05-31 | Trial Unspecified | 02 | N | 240030216 | TRIAL |
| 240013854 | 240007638 | null | 0 | null | 2014-11-20 | 2014-11-25 | Trial Unspecified | 02 | N | 240030241 | TRIAL |
| 240013855 | 240014197 | 0 | 64.3 | Palliative (P) | 2018-10-16 | 2018-10-23 | PACLITAXEL | null | null | 240030247 | PACLITAXEL |
| 240013856 | 240014197 | 1.7 | 0 | Curative (C) | 2016-05-21 | 2016-05-28 | Methotrexate intrathecal | 02 | N | 240030247 | METHOTREXATE INTRATHECAL |
| 240013857 | 240012102 | 1.58 | null | Curative (C) | 2016-02-26 | 2016-03-03 | Trial Unspecified | N | N | 240030251 | TRIAL |
| 240013858 | 240007640 | null | null | Curative (C) | 2018-05-27 | 2018-05-27 | Bevacizumab+Carbo+Pacliaxel | N | N | 240030254 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240013859 | 240007643 | 1.63 | null | Curative (C) | 2015-07-14 | 2015-10-15 | Trial Unspecified | N | N | 240030285 | TRIAL |
| 240013860 | 240007643 | 1.68 | null | null | 2014-08-28 | 2014-09-17 | SMILE | 02 | N | 240030285 | TRIAL |
| 240013862 | 240007645 | 1.72 | 60.1 | Palliative (P) | 2015-05-03 | 2015-05-10 | INTERLACE TRIAL | N | N | 240030321 | INTERLACE TRIAL |
| 240013863 | 240012106 | 1.64 | 47 | Palliative (P) | 2016-11-29 | 2016-12-20 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 240030322 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240013864 | 240012106 | 1.66 | null | Curative (C) | 2014-05-18 | 2014-05-18 | PACLITAXEL | 02 | N | 240030322 | PACLITAXEL |
| 240013865 | 240007649 | 1.75 | 84.3 | Disease modification (D) | 2014-09-26 | 2014-10-17 | Azacitidine | 2 | N | 240030327 | AZACITIDINE |
| 240013866 | 240007650 | 1.73 | 69 | Curative (C) | 2016-11-11 | 2017-04-23 | Methotrexate intrathecal | N | null | 240030332 | METHOTREXATE INTRATHECAL |
| 240013867 | 240007650 | 1.65 | 58.7 | Curative (C) | 2016-02-14 | 2016-02-20 | Methotrexate intrathecal | 2 | N | 240030332 | METHOTREXATE INTRATHECAL |
| 240013868 | 240007656 | 1.7 | 92 | Adjuvant (A) | 2018-07-19 | 2018-07-27 | CHOP - 21 days | 02 | N | 240030350 | CHOP |
| 240013869 | 240007660 | 1.62 | null | Palliative (P) | null | 2016-07-18 | Paclitaxel 7 day | N | N | 240030352 | PACLITAXEL |
| 240013870 | 240007660 | null | 72 | Curative (C) | 2013-11-09 | 2013-11-17 | CHOP | N | N | 240030352 | CHOP |
| 240013871 | 240007662 | 1.68 | 75.7 | Palliative (P) | 2015-03-20 | 2015-03-20 | Bevacizumab+Carbo+Pacliaxel | 99 | null | 240030357 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240013872 | 240014205 | 1.78 | null | Palliative (P) | 2016-01-25 | 2016-05-17 | Bevacizumab 15mg/kg | 01 | N | 240030381 | BEVACIZUMAB |
| 240013873 | 240007666 | 1.6 | null | Palliative (P) | 2014-03-24 | 2014-03-30 | Bevacizumab | 02 | N | 240030419 | BEVACIZUMAB |
| 240013874 | 240007668 | 1.73 | 87.4 | Palliative (P) | 2014-10-03 | 2014-11-02 | Trial Unspecified | N | N | 240030419 | TRIAL |
| 240013875 | 240007671 | 1.77 | 91 | Palliative (P) | 2015-08-19 | 2015-08-23 | Trial Unspecified | null | null | 240030445 | TRIAL |
| 240013876 | 240007673 | 1.81 | 97.5 | Neo-adjuvant (N) | 2014-02-02 | 2014-02-09 | Bevacizumab | null | N | 240030451 | BEVACIZUMAB |
| 240013877 | 240007675 | 1.69 | 59.1 | Curative (C) | 2018-09-13 | 2018-09-13 | Azacitidine | null | N | 240030461 | AZACITIDINE |
| 240013879 | 240007679 | 1.61 | 71 | Palliative (P) | 2015-10-10 | 2015-10-15 | Azacitidine | 1 | N | 240030493 | AZACITIDINE |
| 240013880 | 240007681 | 1.68 | 100 | Disease modification (D) | null | 2015-11-07 | Methotrexate intrathecal | 02 | N | 240030505 | METHOTREXATE INTRATHECAL |
| 240013881 | 240007685 | 1.73 | 75 | Curative (C) | 2016-09-11 | 2016-09-11 | Bevacizumab 7.5mg/kg | Y | N | 240030526 | BEVACIZUMAB |
| 240013882 | 240007687 | 1.6 | null | Palliative (P) | 2017-03-29 | 2017-08-21 | Carboplatin AUC 6 - 10 | N | N | 240030527 | CARBOPLATIN |
| 240013883 | 240007689 | 1.66 | 64 | Curative (C) | null | 2017-07-21 | Carboplatin AUC 6 - 10 | Y | null | 240030529 | CARBOPLATIN |
| 240013884 | 240007693 | 1.68 | 82.4 | Palliative (P) | 2017-05-17 | 2017-06-08 | Bevacizumab 15mg/kg | Y | N | 240030594 | BEVACIZUMAB |
| 240013885 | 240014216 | null | 0 | Palliative (P) | 2015-11-14 | 2015-11-14 | LI-1 TRIAL | 02 | N | 240030601 | TRIAL |
| 240013886 | 240014216 | 1.65 | 52.7 | Disease modification (D) | 2015-10-21 | 2016-01-21 | INTERLACE TRIAL | N | N | 240030601 | INTERLACE TRIAL |
| 240013887 | 240007697 | 1.8 | 74.6 | Curative (C) | 2015-08-31 | 2015-09-24 | INTERLACE TRIAL | N | N | 240030637 | INTERLACE TRIAL |
| 240013888 | 240007700 | 1.5 | 46.1 | Curative (C) | 2018-06-15 | 2018-10-03 | Azacitidine | n | Y | 240030664 | AZACITIDINE |
| 240013889 | 240007702 | null | 61.6 | Palliative (P) | 2017-01-28 | 2017-03-07 | BEVACIZUMAB + CARBO + PACLITAXEL | null | null | 240030673 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240013890 | 240007704 | 1.65 | 65 | Curative (C) | 2013-09-13 | 2013-09-13 | CHOP - 21 days | Y | N | 240030702 | CHOP |
| 240013891 | 240012138 | null | 50.4 | Curative (C) | 2018-04-16 | 2018-04-21 | INTERLACE TRIAL | 2 | N | 240030707 | INTERLACE TRIAL |
| 240013892 | 240007706 | 1.58 | 50.7 | Neo-adjuvant (N) | 2017-09-22 | 2017-10-17 | Paclitaxel 80mg/m2 day 1 8 15 | N | null | 240030712 | PACLITAXEL |
| 240013893 | 240007708 | 1.7 | 33.7 | Curative (C) | 2016-12-23 | 2017-01-13 | INTERLACE TRIAL | N | N | 240030721 | INTERLACE TRIAL |
| 240013894 | 240007709 | null | null | null | 2016-12-25 | 2016-12-25 | ALCL ALCL 99 Closed BM 1, 2 or 3 | 02 | null | 240030722 | NOT MATCHED |
| 240013895 | 240007710 | 1.69 | 81.9 | Palliative (P) | 2018-11-27 | 2018-12-15 | Bevacizumab 15mg/kg | 02 | N | 240030724 | BEVACIZUMAB |
| 240013896 | 240007713 | 1.64 | null | Palliative (P) | 2018-09-28 | 2018-10-12 | Azacitidine | 02 | N | 240030736 | AZACITIDINE |
| 240013897 | 240007715 | 1.8 | 79.7 | Disease modification (D) | 2018-01-07 | 2018-01-14 | ALCL ALCL 99 Closed BM 1, 2 or 3 | N | N | 240030739 | NOT MATCHED |
| 240013898 | 240007717 | 1.68 | 58.6 | null | 2018-06-16 | 2018-08-13 | Azacitidine | N | N | 240030750 | AZACITIDINE |
| 240013899 | 240012147 | 1.77 | 42.9 | Palliative (P) | 2014-12-24 | 2015-05-19 | BEVACIZUMAB + CARBO + PACLITAXEL | N | null | 240030755 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240013900 | 240007720 | 1.64 | 46.7 | Curative (C) | 2015-07-12 | 2015-07-20 | ALCL ALCL 99 Closed BM 1, 2 or 3 | N | null | 240030756 | NOT MATCHED |
| 240013901 | 240007723 | 1.5 | 86.5 | null | 2017-02-25 | 2017-02-26 | null | N | N | 240030765 | NOT MATCHED |
| 240013902 | 240007725 | null | 62.8 | Palliative (P) | 2018-02-16 | 2018-02-16 | Methotrexate intrathecal | null | null | 240030767 | METHOTREXATE INTRATHECAL |
| 240013903 | 240007728 | 1.9 | null | Palliative (P) | 2016-10-27 | 2016-11-05 | Methotrexate intrathecal | Y | null | 240030787 | METHOTREXATE INTRATHECAL |